Data / New clinical trials / Schizophrenia

New Schizophrenia clinical trials: 328 posted since Nov 2024

Name: New Schizophrenia clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Schizophrenia clinical trials: 328 rows for $16.40, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 15 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/schizophrenia, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 6, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

328 clinical studies in schizophrenia were first posted on ClinicalTrials.gov from November 13, 2024 to November 6, 2026; 68 have an industry sponsor and 224 are recruiting or about to. The newest, NCT07921966, was posted on November 6, 2026: Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult... (Neurelis, Inc.).

The request: Every new Schizophrenia clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

328New trials
68Industry sponsored
224Recruiting or not yet
November 6, 2026Latest posted

Newest trials

The newest 100 of 328, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 6, 2026	NCT07921966	Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult Participants	Neurelis, Inc.	Phase 1	Not yet recruiting	Healthy Adult Participants	24		clinicaltrials.gov
November 6, 2026	NCT07921667	Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual Treatment	International University of La Rioja	Observational	Not yet recruiting	Bipolar Disorder (BD), SCHIZOPHRENIA 1 (Disorder)	30	Spain	clinicaltrials.gov
November 4, 2026	NCT07917637	Ashwagandha Added to Risperidone for Quality of Life and Inflammation in Schizophrenia	Athitah Pratiwi	Not applicable	Completed	Schizophrenia	60	Indonesia	clinicaltrials.gov
November 3, 2026	NCT07913100	Real-World Impact of TV-44749 in Adults With Schizophrenia	Teva Branded Pharmaceutical Products R&D LLC	Observational	Not yet recruiting	Schizophrenia	1,085		clinicaltrials.gov
November 3, 2026	NCT07911787	Phase 3 Study of HS-10380 for Acute Schizophrenia in Chinese Adults	Jiangsu Hansoh Pharmaceutical Co., Ltd.	Phase 3	Not yet recruiting	SCHIZOPHRENIA 1 (Disorder)	476	China	clinicaltrials.gov
November 2, 2026	NCT07908680	A Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable Schizophrenia	Novartis Pharmaceuticals	Phase 1	Recruiting	Schizophrenia	36	United States	clinicaltrials.gov
October 29, 2026	NCT07902518	Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations	Ciusss de L'Est de l'Île de Montréal	Not applicable	Recruiting	Auditory Verbal Hallucinations, Schizophrenia, Schizoaffective Disorder, Psychotic Disorders	12	Canada	clinicaltrials.gov
October 28, 2026	NCT07900893	Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 3	Washington University School of Medicine	Not applicable	Recruiting	Schizophrenia / Schizoaffective Disorder, SCHIZOPHRENIA 1 (Disorder), Healthy Adult	10,000	United States	clinicaltrials.gov
October 27, 2026	NCT07898852	Integrated Psychoeducation Program for Internalized Stigma in Schizophrenia	Dokuz Eylul University	Not applicable	Not yet recruiting	Schizophrenia, Schizoaffective Disorder, Internalized Stigma, Social Stigma	50	Turkey (Türkiye)	clinicaltrials.gov
October 22, 2026	NCT07887997	Temporal Interference Stimulation (TI) for Schizophrenia (SCZ)	Anhui Medical University	Not applicable	Not yet recruiting	Schizophrenia	100	China	clinicaltrials.gov
October 19, 2026	NCT07881016	French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism...	Fondation FondaMental	Not applicable	Recruiting	Schizophrenia / Schizoaffective Disorder, First Episode Psychosis (FEP), Bipolar Disorder (BD), Major Depressive...	3,000	France	clinicaltrials.gov
October 16, 2026	NCT07879131	A Mobile App to Support Mood, Daily Routines and Medication Adherence in Adults With Severe Mental Illness	Alexandria University	Not applicable	Not yet recruiting	Severe Mental Illness, Bipolar Disorder, Schizophrenia, Schizoaffective Disorder, Major Depressive Disorder	60	Bahrain	clinicaltrials.gov
October 15, 2026	NCT07876089	Validation and Comparative Multi-Omics Benchmarking of Fluid-Derived Volatilomics Biomarkers for the Prevention and Early Detection of...	University Hospital, Aachen	Observational	Active not recruiting	Schizophrenia / Schizoaffective Disorder	3,692	Germany	clinicaltrials.gov
October 15, 2026	NCT07875790	Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2	Washington University School of Medicine	Not applicable	Not yet recruiting	SCHIZOPHRENIA 1 (Disorder), Schizo Affective Disorder, Healthy Adult	325	United States	clinicaltrials.gov
October 9, 2026	NCT07867964	Feasibility Trial of a Parent Peer-Co-Led Caregiver Group for Pediatric Early Onset Schizophrenia Spectrum Disorders	Boston Children's Hospital	Not applicable	Not yet recruiting	Schizophrenia; Psychosis	20	United States	clinicaltrials.gov
October 8, 2026	NCT07866833	Dysfunction of Respiratory Enzymes in Adults With Mental Illness (DREAM)	King's College London	Not applicable	Completed	Schizophrenia and Other Psychotic Disorders, Healthy Adult	53	United Kingdom	clinicaltrials.gov
October 5, 2026	NCT07858565	Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of...	Bosnalijek D.D	Observational	Recruiting	Schizophrenia, Bipolar Affective Disorder	500	Bosnia and Herzegovina	clinicaltrials.gov
October 2, 2026	NCT07856381	Understanding Lifespan Trajectories of Social Cognition, Brain Microstructure and Iron Dysregulation in Schizophrenia	Medical University Innsbruck	Observational	Recruiting	Healthy Control Subjects, Schizophrenia Diagnosis	180	Austria	clinicaltrials.gov
October 2, 2026	NCT07856368	Neuronavigated rTMS for Treatment-Resistant Auditory Hallucinations	Psychiatric University Hospital, Zurich	Not applicable	Recruiting	Schizophrenia, Auditory Verbal Hallucinations	40	Switzerland	clinicaltrials.gov
October 2, 2026	NCT07853807	Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1	Washington University School of Medicine	Not applicable	Recruiting	SCHIZOPHRENIA 1 (Disorder), Schizoaffective Disorder, Healthy Adult Participants	325	United States	clinicaltrials.gov
October 1, 2026	NCT07853079	Motivational Intervention for Patients With Schizophrenia	University of Geneva, Switzerland	Not applicable	Not yet recruiting	Schizo-affective Disorder, Non Organic Psychosis, Schizophenia Disorder	88		clinicaltrials.gov
September 30, 2026	NCT07850102	Brain Imaging of DSP-2342	Johns Hopkins University	Phase 2	Not yet recruiting	SCHIZOPHRENIA 1 (Disorder)	20	United States	clinicaltrials.gov
September 25, 2026	NCT07843056	A Clinical Trial to Compare the Efficacy and Safety of WAS123 Versus Daily Aripiprazole in the Maintenance Treatment of Patients With...	EMS	Phase 2	Completed	Schizophenia Disorder	121	Brazil	clinicaltrials.gov
September 23, 2026	NCT07837479	Psychological Resilience and Quality of Life Among Caregivers of Patients With Schizophrenia	Assiut University	Observational	Not yet recruiting	Schizophrenia, Caregiver Burden, Quality of Life	130		clinicaltrials.gov
September 22, 2026	NCT07834203	State Representation in Early Psychosis 2	University of Minnesota	Observational	Recruiting	Early Psychosis, Psychosis, Schizophrenia, Bipolar Disorder With Psychosis, Schizoaffective Disorder	500	United States	clinicaltrials.gov
September 15, 2026	NCT07820553	Building a Computational Model of Auditory Hallucinations	King's College London	Observational	Not yet recruiting	Schizophrenia / Schizoaffective Disorder, Schizophrenia and Disorders With Psychotic Feature, Psychosis, SCHIZOPHRENIA...	146		clinicaltrials.gov
September 14, 2026	NCT07818668	tACS for Self-Other Boundary in Schizophrenia	Chunyan Zhu	Not applicable	Recruiting	Schizophrenia / Schizoaffective Disorder	100	China	clinicaltrials.gov
September 11, 2026	NCT07815210	Phase I Trial of HHK101 in Patients With Schizophrenia	Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.	Phase 1	Not yet recruiting	Schizophrenia	88	China	clinicaltrials.gov
September 8, 2026	NCT07806877	Efficacy and Safety of Individualized Sequential Accelerated Theta Burst Stimulation in Improving Cognitive Function in Schizophrenia	Central South University	Not applicable	Not yet recruiting	Schizophrenia / Schizoaffective Disorder, TMS, Cognitive, PET / MR	60		clinicaltrials.gov
September 8, 2026	NCT07805980	A Relation Between Craving Induction and Treatment Response in Deep Transcranial Magnetic Stimulation (dTMS) for Reducing...	Second Xiangya Hospital of Central South University	Not applicable	Recruiting	Schizophrenia, Antipsychotic Induced Weight Gain	30	China	clinicaltrials.gov
September 3, 2026	NCT07802132	A Prospective, Observational, Single-Arm, Multicenter Real-World Study Evaluating the Treatment Pattern, Safety and Effectiveness of...	Zai Lab (Shanghai) Co., Ltd.	Observational	Not yet recruiting	Schizophrenia Disorder	250		clinicaltrials.gov
August 31, 2026	NCT07795554	The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain	Second Xiangya Hospital of Central South University	Not applicable	Recruiting	Schizophrenia Spectrum, Schizophrenia, Antipsychotic Induced Weight Gain	60	China	clinicaltrials.gov
August 26, 2026	NCT07788755	NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia	University of Minnesota	Not applicable	Not yet recruiting	Schizophrenia, Schizoaffective Disorder, Cognitive Impairment, Visual Impairment	168	United States	clinicaltrials.gov
August 24, 2026	NCT07783373	Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia	Bristol-Myers Squibb	Observational	Active not recruiting	Schizophrenia	3,000	United States	clinicaltrials.gov
August 24, 2026	NCT07781748	Improving Quality of Informal Care for People With Schizophrenia	Chinese University of Hong Kong	Not applicable	Not yet recruiting	Schizophrenia	228	China	clinicaltrials.gov
August 24, 2026	NCT07781007	Effectiveness of a Board Game Intervention on Cognitive and Functional Outcomes in Older Adults With Schizophrenia	Kaohsiung Kai-Suan Psychiatric Hospital	Not applicable	Not yet recruiting	Schizophrenia	76	Taiwan	clinicaltrials.gov
August 21, 2026	NCT07779226	DecNef for Auditory Verbal Hallucinations (AVH) in Schizophrenia	Columbia University	Not applicable	Not yet recruiting	Schizophrenia Disorder, Schizoaffecitve Disorder	51	United States	clinicaltrials.gov
August 19, 2026	NCT07772349	Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3)	The University of Texas Health Science Center, Houston	Not applicable	Not yet recruiting	Schizophrenia	120	United States	clinicaltrials.gov
August 18, 2026	NCT07770282	Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome	All India Institute of Medical Sciences, Bhubaneswar	Phase 3	Not yet recruiting	Schizophrenia Disorder, Metabolic Syndrome, Antipsychotic-induced Weight Gain, Cardiovascular Risk, Insulin Resistance	600		clinicaltrials.gov
August 18, 2026	NCT07769749	Basal Stimulation Therapy in Adults With Schizophrenia Requiring Institutional Care	The Jerzy Kukuczka Academy of Physical Education in Katowice	Not applicable	Not yet recruiting	SCHIZOPHRENIA 1 (Disorder)	12	Poland	clinicaltrials.gov
August 17, 2026	NCT07767526	Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation	Shanghai Mental Health Center	Phase 1/2	Not yet recruiting	Schizophrenia, Antipsychotic Drug	46	China	clinicaltrials.gov
August 12, 2026	NCT07759895	Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia	Amit Lotan	Phase 2	Recruiting	Schizoaffecitve Disorder, Schizophrenia and Schizoaffective Disorder, Schizophrenia and Predominant Negative Symptoms	80	Israel	clinicaltrials.gov
August 12, 2026	NCT07759869	A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia	Jiangsu Hansoh Pharmaceutical Co., Ltd.	Phase 3	Not yet recruiting	SCHIZOPHRENIA 1 (Disorder)	500	China	clinicaltrials.gov
August 11, 2026	NCT07758049	Aerobic, Resistance and Inspiratory Muscle Training in Adults With Severe Mental Disorder	Universidad Pablo de Olavide	Not applicable	Completed	Severe Mental Disorder	49	Spain	clinicaltrials.gov
August 11, 2026	NCT07757750	Simulation-Based Schizophrenia Training in Nursing Education	Medipol University	Not applicable	Completed	SCHIZOPHRENIA 1 (Disorder), Simulation Based Learning, Nursing Students	105	Turkey (Türkiye)	clinicaltrials.gov
August 10, 2026	NCT07755605	Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder	Samsung Medical Center	Not applicable	Recruiting	Schizophrenia, Schizoaffecitve Disorder	60	South Korea	clinicaltrials.gov
August 5, 2026	NCT07748078	Snoezelen Therapy in Adults With Alcohol Dependence and Adults With Schizophrenia	The Jerzy Kukuczka Academy of Physical Education in Katowice	Not applicable	Not yet recruiting	SCHIZOPHRENIA 1 (Disorder), Alcohol Use Disorder, Alcohol Dependence (Primary Condition)	140	Poland	clinicaltrials.gov
August 4, 2026	NCT07745140	The Effect of Combined Brain Stimulation and Exercise for Improving Cognitive Function in Schizophrenia	The Hong Kong Polytechnic University	Not applicable	Not yet recruiting	Schizophrenia, Cognitive Functions	66	Hong Kong	clinicaltrials.gov
August 4, 2026	NCT07744113	An Expanded Access Program (EAP) for OLZ/SAM in Pediatric Participants With Schizophrenia or Bipolar I Disorder (ALKS 3831-315)	Alkermes, Inc.	Not applicable	Available	Bipolar 1 Disorder, Schizophrenia Disorder	Not listed	United States	clinicaltrials.gov
August 3, 2026	NCT07742280	A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Brexpiprazole for Extended-Release Injection in Subjects With...	Bostal Drug Delivery Co., Ltd	Phase 2/3	Not yet recruiting	Schizophrenia	16		clinicaltrials.gov
August 3, 2026	NCT07741981	Treatment Resistance in Psychiatric Disorders: the Search for Biological Markers Predictive of Response to Treatment	Centre Hospitalier St Anne	Not applicable	Recruiting	Schizophrenia, Treatment Resistant Depression (TRD), Bipolar Disorder (BD), Catatonia, Obsessive Compulsive Disorder...	700	France	clinicaltrials.gov
July 29, 2026	NCT07734493	A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia	Leal Therapeutics, Inc	Phase 1	Recruiting	Schizophrenia	90	United States	clinicaltrials.gov
July 23, 2026	NCT07722728	A Study to Investigate Pharmacokinetics, Safety, and Tolerability of B2227 Extended-Release Injectable Suspension and Vraylar® in...	Bostal Drug Delivery Co., Ltd	Phase 2/3	Not yet recruiting	Schizophrenia	84		clinicaltrials.gov
July 21, 2026	NCT07716969	TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis	Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital	Observational	Recruiting	Psychosis, Schizo Affective Disorder, SCHIZOPHRENIA 1 (Disorder)	250	Denmark	clinicaltrials.gov
July 20, 2026	NCT07715253	Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in Schizophrenia	New York State Psychiatric Institute	Phase 1	Not yet recruiting	Schizoaffective Disorder, Schizophreniform Disorder, Schizophrenia	100		clinicaltrials.gov
July 20, 2026	NCT07713849	Transition Care for FEP	University of Chicago	Observational	Recruiting	Schizoaffective Disorders, Bipolar Disorder With Psychotic Features, Schizophrenia Disorders, Major Depressive Disorder...	75	United States	clinicaltrials.gov
July 17, 2026	NCT07710989	LIFU Effects & Outcomes: Mechanisms Evaluating Striatal Systems Imaging (LEO MESSI)	University of California, San Francisco	Not applicable	Not yet recruiting	Schizophrenia, Auditory Hallucinations	12	United States	clinicaltrials.gov
July 16, 2026	NCT07708402	Healing Stigma Through Stories	National Yang Ming Chiao Tung University	Not applicable	Not yet recruiting	Schizophrenia / Schizoaffective Disorder	24		clinicaltrials.gov
July 15, 2026	NCT07703956	Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults	Vigonvita Life Sciences	Phase 2	Not yet recruiting	Schizophrenia	500	China	clinicaltrials.gov
July 14, 2026	NCT07703670	MicroRNAs as Biomarkers in First Episode Schizophrenia	Northwell Health	Not applicable	Recruiting	Schizophrenia Disorder, Schizophreniform Disorder, Schizoaffective Disorder, Psychosis Not Otherwise Specified (NOS)	160	United States	clinicaltrials.gov
July 14, 2026	NCT07702526	Eye-Movement Intervention for Cognitive Impairment Across Schizophrenia Spectrum	Shanghai Mental Health Center	Not applicable	Not yet recruiting	Schizophrenia, Cognitive Impairment, Clinical High Risk for Psychosis	160		clinicaltrials.gov
July 14, 2026	NCT07701343	tACS for Working Memory in Schizophrenia	Central South University	Not applicable	Recruiting	Schizophrenia, Working Memory	30	China	clinicaltrials.gov
July 10, 2026	NCT07696000	The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic...	DINA KEUMALA SARI	Not applicable	Recruiting	Schizophrenia / Schizoaffective Disorder	100	Indonesia	clinicaltrials.gov
July 9, 2026	NCT07692984	The Effect of Comorbid Alcohol/Substance Use	Abant Izzet Baysal University	Observational	Recruiting	Alcohol Abuse, Alcohol Use Disorder, Substance Use Disorders, Severe Mental Disorder, Schizophrenia, Bipolar Disorder...	297	Turkey (Türkiye)	clinicaltrials.gov
July 7, 2026	NCT07686263	Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia	Karuna Therapeutics, Inc., a Bristol Myers Squibb company	Phase 3	Recruiting	Schizophrenia	472	Argentina, Bulgaria, Czechia, Poland, Romania, Spain, United States	clinicaltrials.gov
July 6, 2026	NCT07682935	Investigation of the Effects of Angling as Supportive Therapy in Schizophrenia Treatment on Serum Parameters, Anxiety, Depression, and...	Firat University	Not applicable	Recruiting	Angling, Supportive Therapeutic, Schizophrenia	60	Turkey (Türkiye)	clinicaltrials.gov
July 2, 2026	NCT07680959	Combining HD-tDCS and iTBS in Treating Negative Symptoms of Schizophrenia	Tri-Service General Hospital (TSGH)	Not applicable	Enrolling by invitation	Negative Symptoms in Schizophrenia, Brain Stimulation Intervention	100	Taiwan	clinicaltrials.gov
July 2, 2026	NCT07680946	Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia	TG Therapeutics, Inc.	Phase 2	Recruiting	Schizophrenia	60	United States	clinicaltrials.gov
July 2, 2026	NCT07680114	Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy Controls	University of Wisconsin, Madison	Not applicable	Recruiting	Schizophrenia	20	United States	clinicaltrials.gov
June 30, 2026	NCT07674914	A Cognitive Mobile Intervention for Motivation in Psychotic Disorders	University of Alabama at Birmingham	Phase 1/2	Not yet recruiting	Schizophrenia / Schizoaffective Disorder	45	United States	clinicaltrials.gov
June 26, 2026	NCT07671261	SEEG-Guided DBS for Schizophrenia	Ruijin Hospital	Not applicable	Recruiting	Schizophrenia Disorders, Schizo Affective Disorder	46	China	clinicaltrials.gov
June 26, 2026	NCT07671040	A Pilot Study of Adjunctive Structured Supportive Psychotherapy in Schizophrenia	Hasanuddin University	Not applicable	Completed	Schizophrenia, Cognitive and Executive Dysfunction, Neuroinflammation	44	Indonesia	clinicaltrials.gov
June 22, 2026	NCT07659938	Frontal Gamma Coherence Neurofeedback for Patients With Schizophrenia	BioSignal Solutions LLC	Not applicable	Not yet recruiting	Schizophrenia, Schizoaffective	30	United States	clinicaltrials.gov
June 22, 2026	NCT07658898	dACC-Targeted Temporal Interference for Negative and Cognitive Symptoms in Schizophrenia	Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University	Not applicable	Recruiting	Schizophrenia Disorder	74	China	clinicaltrials.gov
June 22, 2026	NCT07658391	Optimizing CBSST With Executive Function Training for Schizophrenia (R33)	University of California, San Diego	Not applicable	Not yet recruiting	Schizophrenia, Schizoaffective Disorder	106	United States	clinicaltrials.gov
June 18, 2026	NCT07656870	Exploring the Genetics of Schizophrenia in Manitoba	University of Manitoba	Observational	Not yet recruiting	Schizophrenia, Healthy (Controls)	1,500	Canada	clinicaltrials.gov
June 18, 2026	NCT07656558	ACT-Based Psychoeducation for Caregivers of Patients With Schizophrenia	Aydin Adnan Menderes University	Not applicable	Not yet recruiting	SCHIZOPHRENIA 1 (Disorder)	60	Turkey (Türkiye)	clinicaltrials.gov
June 17, 2026	NCT07652866	Mechanisms of Sulforaphane Supplementation in Alleviating Negative Symptoms and Cognitive Impairment in Schizophrenia	Second Xiangya Hospital of Central South University	Not applicable	Not yet recruiting	Schizophrenia Disorder	60	China	clinicaltrials.gov
June 16, 2026	NCT07649993	Non-Coding RNAs Gene Expression in Psychiatric Disorders	Carmen Concerto	Observational	Not yet recruiting	Schizophrenia Disorders, Major Depression, Bipolar Affective Disorders, Obsessive Compulsive Disorder (OCD), Anxiety...	384	Italy	clinicaltrials.gov
June 15, 2026	NCT07647380	TIS for Improving Cognitive Impairment in Schizophrenia	Central South University	Not applicable	Recruiting	Schizophrenia Disorder, Cognitive Impairments	50	China	clinicaltrials.gov
June 12, 2026	NCT07645443	FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis	Stephanie Mehl	Not applicable	Recruiting	Delusional Disorder, Brief Psychotic Disorder, Schizophreniform Disorder, Schizophrenia / Schizoaffective Disorder...	252	Germany	clinicaltrials.gov
June 11, 2026	NCT07643714	Effects of ACT-Based Psychoeducation on Caregivers of Individuals With Mental Disorders	Zeynep Özkök	Not applicable	Completed	Caregiver Burden, Mental Disorders	64	Turkey (Türkiye)	clinicaltrials.gov
June 4, 2026	NCT07626034	A Positron Emission Tomography (PET) Study to Evaluate Dopamine D2 and D3 Receptor Occupancy by SIPI6398	Shanghai Zhongze Therapeutics Co., Ltd.	Phase 1/2	Not yet recruiting	Schizophrenia Disorder	9		clinicaltrials.gov
June 3, 2026	NCT07623928	Developing a Virtual Reality-assisted Intervention for Emotion Regulation Difficulties in Psychosis	King's College London	Not applicable	Not yet recruiting	Psychosis, SCHIZOPHRENIA 1 (Disorder), Schizophrenia and Related Disorders	15	United Kingdom	clinicaltrials.gov
June 1, 2026	NCT07618767	A Computational Neuroscience Perspective on the Shared Social Cognitive Deficits of Autism and Schizophrenia	National Taiwan University Hospital	Observational	Active not recruiting	Schizophrenia, Autism Spectrum Disorder	267	Taiwan	clinicaltrials.gov
June 1, 2026	NCT07618338	Virtual Reality-Based Smoking Cessation Treatment in Patients With Schizophrenia	Dokuz Eylul University	Not applicable	Completed	Schizophrenia Disorder	160	Turkey (Türkiye)	clinicaltrials.gov
June 1, 2026	NCT07616999	A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and Relapse	The University of Hong Kong	Observational	Recruiting	Schizophrenia	178	China	clinicaltrials.gov
May 29, 2026	NCT07615426	A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia	Janssen Research & Development, LLC	Phase 1	Recruiting	Schizophrenia	64	United States	clinicaltrials.gov
May 29, 2026	NCT07615075	Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With...	University of Maryland, Baltimore	Phase 4	Not yet recruiting	Schizophrenia, Schizo Affective Disorder, Healthy	40	United States	clinicaltrials.gov
May 27, 2026	NCT07609953	Cognitive Behavioral Therapy Added to Risperidone for Schizophrenia	Hasanuddin University	Not applicable	Completed	Schizophrenia	42	Indonesia	clinicaltrials.gov
May 27, 2026	NCT07608250	Research Sense of Familiarity in Psychotic Patients	University Hospital, Lille	Observational	Completed	Schizophrenia	30	France	clinicaltrials.gov
May 26, 2026	NCT07606014	No Guts No Glory Probiotics	University Medical Center Groningen	Phase 2/3	Recruiting	Patients Using Olanzapine, Quetiapine, Risperidone or Clozapine	112	Netherlands	clinicaltrials.gov
May 22, 2026	NCT07604129	Transcranial Sonography and Machine Learning for Schizophrenia Identification	Taizhou Second People's Hospital	Observational	Not yet recruiting	Schizophrenia	200	China	clinicaltrials.gov
May 22, 2026	NCT07602712	Using Illusions to Boost Social Cognition	Hôpital le Vinatier	Not applicable	Not yet recruiting	Schizophrenia Spectrum Disorders, Social Cognition	60	France	clinicaltrials.gov
May 18, 2026	NCT07593456	NST-SPARK Open-Label Phase 1 STTR (IGNITE)	North Shore Therapeutics, Inc.	Not applicable	Not yet recruiting	Schizophrenia / Schizoaffective Disorder	30	United States	clinicaltrials.gov
May 18, 2026	NCT07592884	Rochester Forensic Assertive Community Treatment Model in Minnesota	University of Rochester	Not applicable	Completed	Schizophrenia, Bipolar Disorder, Criminal Behavior	40	United States	clinicaltrials.gov
May 18, 2026	NCT07592169	Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia	University of California, San Diego	Phase 2	Not yet recruiting	SCHIZOPHRENIA 1 (Disorder), Schizoaffecitve Disorder	104		clinicaltrials.gov
May 14, 2026	NCT07586150	Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)	Ludwig-Maximilians - University of Munich	Not applicable	Not yet recruiting	Severe Mental Illness, Depression / Major Depressive Disorder, Bipolar Disorder (BD), Schizophrenia	140	Austria, Germany, Netherlands	clinicaltrials.gov
May 13, 2026	NCT07585383	A Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of KR23248 Capsules in Healthy Adult...	Jiangxi Kvvit Pharmaceutical Co., Ltd.	Phase 1	Not yet recruiting	Schizophrenia	66		clinicaltrials.gov
May 8, 2026	NCT07575516	Effectiveness of Ashwagandha in Schizophrenia Patients on Risperidone	Hasanuddin University	Phase 2	Completed	Schizophrenia Patients, Neuroinflammation	80	Indonesia	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Shanghai Mental Health Center	9	August 17, 2026
Bristol-Myers Squibb	8	August 24, 2026
Central South University	6	September 8, 2026
Tianjin Anding Hospital	6	February 6, 2026
Neurocrine Biosciences	6	December 17, 2025
King's College London	5	October 8, 2026
Hasanuddin University	5	June 26, 2026
University of Alabama at Birmingham	4	June 30, 2026
University of California, San Diego	4	June 22, 2026
Otsuka Pharmaceutical Development & Commercialization, Inc.	4	April 24, 2026
Douglas Mental Health University Institute	4	February 23, 2026
Jiangsu Hansoh Pharmaceutical Co., Ltd.	3	November 3, 2026
Washington University School of Medicine	3	October 28, 2026
Dokuz Eylul University	3	October 27, 2026
Anhui Medical University	3	October 22, 2026
Assiut University	3	September 23, 2026
University of Minnesota	3	September 22, 2026
Second Xiangya Hospital of Central South University	3	September 8, 2026
The University of Texas Health Science Center, Houston	3	August 19, 2026
The Hong Kong Polytechnic University	3	August 4, 2026

By phase

Phase	New trials	Latest
Not applicable	190	November 4, 2026
Observational	57	November 6, 2026
Phase 3	22	November 3, 2026
Phase 2	22	September 30, 2026
Phase 1	18	November 6, 2026
Phase 4	8	May 29, 2026
Phase 1/2	5	August 17, 2026
Phase 2/3	3	August 3, 2026
Early phase 1	3	January 15, 2026

By country

Country	New trials	Latest
United States	90	November 2, 2026
China	49	November 3, 2026
Turkey (Türkiye)	36	October 27, 2026
France	15	October 19, 2026
Canada	14	October 29, 2026
Taiwan	12	August 24, 2026
Spain	11	November 6, 2026
Indonesia	8	November 4, 2026
Germany	8	October 15, 2026
Denmark	8	July 21, 2026
United Kingdom	7	October 8, 2026
Italy	7	June 16, 2026
India	7	March 20, 2026
Romania	6	July 7, 2026
Japan	6	February 20, 2026
Poland	5	August 18, 2026
Bulgaria	5	July 7, 2026
Netherlands	5	May 26, 2026
Austria	4	October 2, 2026
Israel	4	August 12, 2026
Hong Kong	4	August 4, 2026
Norway	4	July 25, 2025
Argentina	3	July 7, 2026
Belgium	3	April 3, 2026
Hungary	3	February 20, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.